BROILER PMX NO. 1620
-
amprolium and
ethopabate powder
Huvepharma, Inc.
----------
AMPROL PLUSFRONT PANEL
NADA 13-461
Approved by the FDA
AMPROL PLUS Product 956750
(amprolium with ethopabate)
Type A Medicated Article
AMPROL PLUS (amprolium, ethopabate) is intended for use as an aid in the
prevention of coccidiosis (1) in broiler chickens and (2) in replacement chickens
where immunity to coccidiosis is not desired.
ACTIVE DRUG INGREDIENTS: Amprolium .............................. 25%
Ethopabate ....................... 0.8%
INGREDIENTS: Corn Gluten Feed and Soybean Oil
SEE DIRECTIONS ON BACK PANEL
Manufactured by:
HUVEPHARMA, INC.
St. Louis, MO 63116
Distributed by:
Huvepharma, Inc.
Peachtree City, GA 30269
® AMPROL PLUS and ® AMPROL are registered trademarks of Huvepharma, Inc.
Net Wt.: 50 LB (22.68 kg)
Take Time Image
Take Time Image
Back Panel
WARNINGKeep this and all drugs out of the reach of children. NOT FOR HUMAN USE
The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse effects,
obtain an MSDS or for assistance, contact Huvepharma at 1-877-4AMPROL
MIXING DIRECTIONS
AMPROL PLUS (amprolium, ethopabate) should be thoroughly and evenly mixed in the feed. AMPROL PLUS may be used
to manufacture a Type C medicated feed in the concentration range of 0.0125% - 0.025% amprolium and 0.0004% ethopabate.
One pound of AMPROL PLUS should be mixed with one ton of non-medicated feed to produce a Type C medicated
feed containing 0.0125% amprolium / 0.0004% ethopabate. One pound of AMPROL PLUS and one pound of AMPROL
(amprolium) 25% mixed with one ton of non-medicated feed will produce a feed containing 0.025% amprolium and
0.0004% ethopabate.
To aid in the even distribution of AMPROL PLUS in the finished feed, prepare a mixture of AMPROL PLUS in a portion of complete
feed ingredient before mixing into the finished ration. Blend the mixture with the remainder of the finished feed and mix thoroughly.
SUGGESTED DIRECTIONS FOR FEED TAGS
Use Directions
CHICKENS: For most field conditions as they exist under modern management practices use 0.0125% amprolium 0.0004%
ethopabate Type C medicated feed. Where severe coccidiosis conditions exist, use 0.025% amprolium-0.0004% ethopabate Type C
medicated feed. Increasing levels of Amprolium may not prevent coccidiosis caused by strains of Eimeria commonly found to be
resistant to Amprolium.
Use amprolium-ethopabate Type C medicated feed as the only ration from the time birds are placed on litter until past the time
when coccidiosis is ordinarily a hazard.
CAUTION
Not for laying hens.
Withdraw 5 days before slaughter for broiler chickens.
Use as the sole Source of amprolium.
Do not use amprolium-ethopabate Type C medicated feed as a treatment for outbreaks of coccidiosis.
Do not change the litter while giving this feed unless absolutely necessary.
If losses exceed 0.5% in a 2-day period, obtain an accurate diagnosis, and follow the instructions of your veterinarian or poultry
pathologist. Losses may result from intercurrent disease or other conditions affecting drug intake which can contribute to the
virulence of coccidiosis under field conditions.
Do not use in feeds containing bentonite.
Restricted Drug (California) - Use Only as Directed.
AMPROL PLUS
(amprolium with ethopabate)
Type A Medicated Article 1075-1557-04
Dated 09-2007
Bag Label Image
| BROILER PMX NO. 1620
amprolium powder |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NADA | NADA013461 | 06/29/2009 | |
| Labeler - Huvepharma, Inc. (619153559) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Huvepharma, Inc. | 883128204 | manufacture, analysis, pack, label, medicated animal feed manufacture | |